Acquisition of androgen-mediated expression of mouse vas deferens protein (MVDP) gene in cultured epithelial cells and in vas deferens during postnatal development.
We used cultured vas deferens epithelial cells (VDECs) as a model system to determine the conditions that allow mouse vas deferens protein (MVDP) gene expression and acquisition of androgen responsiveness. On the basis of Northern blot analysis, the mvdp gene is constitutively expressed at very low levels in prepubertal VDECs grown on collagen-coated plastic or on microporous membrane inserts. In the presence of dihydrotestosterone (DHT), mvdp messenger RNA levels dramatically increased in cells cultured on microporous membrane inserts and stayed unchanged in cells grown on matrix-coated plastic. Epithelial cells derived from fetal vas deferens were able to synthesize MVDP in response to DHT, and the presence of fetal mesenchymal cells did not influence MVDP production. Providing the cells with a culture procedure that permits access to the basolateral membranes and caters to the polarity requirements of the cell is a prerequisite for androgen induction of MVDP gene expression. The results also point to a role for epidermal growth factor, insulin, and tyrosine kinase activity in mediating the action of androgen on mvdp gene expression. In vivo studies show that the first expression of the mvdp gene between 5 and 7 days postpartum is not associated with major structural changes in the epithelium. The acquisition of a mature phenotype by epithelial and peritubular contractile cells, between 10 and 20 days, correlates with androgen dependency of the mvdp gene. We propose that cell differentiation and polarization on a matrix-coated microporous membrane reproduces some of the events that are necessary for acquisition of androgenic responsiveness of the mvdp gene during postnatal development.
Manin
M
M
Reproduction et Développement, UMR CNRS 6547, Université Blaise Pascal, Aubiere, France. Michele.Manin@geem.univ-bpclermont.fr
Martinez
A
A
Van Der Schueren
B
B
Reynaert
I
I
Jean
C
C
D016475:3T3 Cells; D000375:Aging / Q000502:physiology*; D000449:Aldehyde Reductase; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D015415:Biomarkers; D016764:Cell Polarity / Q000502:physiology; D002478:Cells, Cultured; D003470:Culture Media; D013196:Dihydrotestosterone / Q000494:pharmacology*; D004815:Epidermal Growth Factor / Q000378:metabolism; D004847:Epithelial Cells / Q000502:physiology; D007328:Insulin / Q000378:metabolism; D008297:Male; D008648:Mesoderm / Q000166:cytology / Q000502:physiology; D051379:Mice; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D014649:Vas Deferens / Q000187:drug effects / Q000502:physiology*
D015415:Biomarkers; D003470:Culture Media; D007328:Insulin; D011506:Proteins; D012333:RNA, Messenger; D013196:Dihydrotestosterone; D004815:Epidermal Growth Factor; C066498:Akr1b7 protein, mouse; D000449:Aldehyde Reductase; D011505:Protein-Tyrosine Kinases